HomePBIGF • OTCMKTS
add
Paradigm Biopharmaceuticals Ltd
Previous close
$0.18
Day range
$0.19 - $0.19
Year range
$0.17 - $0.67
Market cap
98.05M AUD
Avg Volume
2.79K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 25.07M | 53.09% |
Net income | -24.48M | -53.63% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -25.04M | -53.22% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 33.55M | -60.02% |
Total assets | 45.04M | -49.11% |
Total liabilities | 11.24M | -24.26% |
Total equity | 33.80M | — |
Shares outstanding | 351.50M | — |
Price to book | 1.79 | — |
Return on assets | -139.18% | — |
Return on capital | -183.88% | — |
Cash Flow
Net change in cash
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -24.48M | -53.63% |
Cash from operations | -25.51M | -187.38% |
Cash from investing | 23.10K | 0.00% |
Cash from financing | 14.15M | -54.57% |
Net change in cash | -11.39M | -151.48% |
Free cash flow | -15.22M | -56.25% |
About
Founded
2014
Website